Lissun, a single specialty healthtech startup focused on children with special needs and developmental delay, today announced the closure of its Series A funding round of Rs 48 crore.
The round was led by Colossa Ventures, with participation from Physis Capital and existing investors including RPSG Capital Ventures, Ivycap Ventures, Rainmatter, Multiply Ventures and SucSEED Ventures, as well as new partners New Age India Fund and Beyond Capital Ventures.
Lissun operates through its child care brand, Sunshine by LISSUN, which is building a growing network of child development centers across India alongside a suite of AI-led platforms and tools.
The startup said it will use the fresh capital to expand Sunshine by LISSUN centers in key cities, build AI-led solutions on its proprietary technology and data, and strengthen clinical processes across the network.
“We have always believed technology would be central to Lissun’s vision. Today, our AI tools largely support therapists and parents — but the bigger opportunity is building AI-led solutions on our own proprietary technology and data, with the potential to reach millions of children across India who lack access to quality developmental care. This fundraise lets us scale both our centers and that platform, to serve a much larger population of children and families,” said Krishna Veer Singh, Co-founder and CEO, Lissun.
Commenting on this, Tarun Gupta, Co-founder, Sunshine by Lissun, “Our goal with Sunshine by LISSUN is to build an ecosystem where technology, therapists and people come together for every child with special needs. This next phase lets us scale that single specialty, AI-led model — not just to support our therapists and centers, but to build proprietary AI-led products that can reach far more children than our centers alone ever could. We are grateful to our investors for the faith they have shown in Sunshine by LISSUN through this round.”
